Fairpointe Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,000
Closed -$40K 77
2020
Q1
$40K Hold
10,000
0.01% 75
2019
Q4
$85K Hold
10,000
0.01% 75
2019
Q3
$68K Hold
10,000
﹤0.01% 78
2019
Q2
$83K Hold
10,000
﹤0.01% 78
2019
Q1
$92K Hold
10,000
﹤0.01% 79
2018
Q4
$109K Buy
+10,000
New +$109K ﹤0.01% 82